Website: Vir Biotechnology
Business Area(s):
Description:
Vir is focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir Biotechnology will be partnering with Alnylam Pharmaceuticals to identify siRNA therapeutics to treat COVID-19. Vir Biotechnology has also identified two monoclonal antibodies that bind to SARS-CoV-2 and is working with WuXi Biologics to commercialize them. These antibodies target the spike (S) protein of the virus by entering through the cellular receptor ACE2.
Career Page(s):
Location(s):
San Francisco
CA
United States
See map: Google Maps